At1g02060 Antibody

What is At1g02060 protein and what is the significance of its antibody in plant research?

At1g02060 is a gene in Arabidopsis thaliana (Mouse-ear cress), a model organism widely used in plant molecular biology. The protein encoded by this gene is recognized by the At1g02060 antibody, which was developed as part of comprehensive efforts to create immunological tools for plant research. The antibody is particularly valuable for protein localization studies at subcellular, cellular, and tissue levels, contributing to better understanding of protein function, protein-protein interactions, and regulatory networks within plant cells. This type of resource is crucial for researchers engaged in post-genomic studies and integrative systems biology approaches to understanding plant development and physiology .

What applications is the At1g02060 antibody validated for?

The At1g02060 antibody has been specifically tested and validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications as indicated in the product specifications. These techniques are fundamental for detecting and quantifying the target protein in plant tissue samples. The antibody is developed through antigen affinity purification methods to ensure specificity for the target protein, maximizing its utility in these applications .

What are the optimal storage conditions for maintaining At1g02060 antibody activity?

For optimal preservation of antibody activity, the At1g02060 antibody should be stored at either -20°C or -80°C immediately upon receipt. It's critical to avoid repeated freeze-thaw cycles as these can significantly degrade antibody quality and performance. The antibody is supplied in a liquid form with a storage buffer consisting of 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4, which helps maintain stability during storage. When handling, aliquoting the antibody upon first thaw is recommended to minimize the need for repeated freezing and thawing of the stock solution .

How does antibody production method affect quality for plant protein detection?

Research has demonstrated significant differences in success rates between antibodies produced using synthetic peptides versus recombinant proteins. According to comprehensive studies with Arabidopsis root proteins, the success rate with peptide antibodies was notably low, with only one out of 24 antibodies working satisfactorily. The primary challenge with peptide antibodies relates to epitope prediction, as computational methods typically identify continuous epitopes, while many natural epitopes are discontinuous and involve amino acid sequences brought together by the protein's tertiary structure. Synthetic peptides may not fold correctly and consequently fail to generate antibodies recognizing the native protein structure. In contrast, recombinant protein approaches showed much higher success rates, with 38 out of 70 antibodies (55%) detected signals with high confidence after affinity purification .

How can researchers validate At1g02060 antibody specificity in experimental systems?

Validation of antibody specificity requires a multi-faceted approach:

• Mutant background testing: The most definitive validation method involves comparing antibody detection in wild-type versus null mutant backgrounds. For example, in studies with LAX2 (LIKE AUX1-2) antibody, strong signals were detected in wild-type Columbia roots but not in null lax2 mutants, confirming specificity.

• Western blot analysis: Perform western blotting with wild-type and mutant/knockout samples, looking for the presence of bands at the expected molecular weight in wild-type samples and absence or alteration in mutants.

• Immunolocalization patterns: Compare observed localization patterns with known or predicted subcellular locations based on computational analysis or published data with fluorescent protein fusions.

• Cross-reactivity assessment: Use bioinformatic analysis to identify potential cross-reactive proteins by searching sequence databases with BLAST, setting a 40% similarity score threshold at the amino acid level as a guideline for potential cross-reactivity .

What strategies can address cross-reactivity concerns in multi-gene family studies using At1g02060 antibody?

When working with proteins from multi-gene families where obtaining unique sequences for antibody production is challenging, researchers should implement the following strategies:

How can At1g02060 antibody be integrated with subcellular markers for co-localization studies?

For effective co-localization studies using At1g02060 antibody with subcellular markers:

• Complementary marker selection: Choose established subcellular markers with non-overlapping spectral properties to enable clear distinction between signals. Common markers include BiP (endoplasmic reticulum), γ-cop (Golgi), PM-ATPase (plasma membrane), and MDH (plastid).

• Sequential immunostaining protocol:

  • Fix tissue samples using 4% paraformaldehyde

  • Perform cell wall digestion with appropriate enzymes

  • Block with bovine serum albumin solution

  • Incubate with primary antibodies (At1g02060 antibody and marker antibody) either sequentially or simultaneously if raised in different species

  • Apply fluorescent-conjugated secondary antibodies with distinct emission spectra

  • Counterstain nuclei if needed

  • Mount in anti-fade medium before microscopy

• Controls: Include single-antibody controls to assess bleed-through, as well as no-primary-antibody controls to evaluate non-specific binding of secondary antibodies.

• Imaging parameters: Use sequential scanning on confocal microscopes to minimize channel cross-talk, and apply appropriate resolution settings to accurately capture co-localization patterns .

What considerations are important when designing experimental controls for At1g02060 antibody immunolocalization?

When conducting immunolocalization experiments with At1g02060 antibody, implement these critical controls:

• Pre-immune serum control: Compare staining patterns between the specific antibody and pre-immune serum from the same animal to identify non-specific binding.

• Peptide competition assay: Pre-incubate the antibody with excess purified antigen before application to samples, which should abolish specific labeling while leaving non-specific binding unaffected.

• Genetic controls: Include tissues from knockout/knockdown lines where the target protein is absent or reduced, which provides the most stringent control for antibody specificity.

• Dilution series: Perform immunostaining with a range of antibody dilutions to determine optimal concentration that maximizes specific signal while minimizing background.

• Cross-species controls: If applicable, test the antibody on related species where the protein is either conserved or absent to evaluate specificity across evolutionary distance.

• Secondary antibody-only controls: Omit primary antibody but include all other steps to identify non-specific binding of secondary reagents .

What are the optimal conditions for using At1g02060 antibody in Western blotting?

For optimal Western blotting results with At1g02060 antibody, researchers should consider:

• Sample preparation:

  • Extract proteins from plant tissues using a buffer containing appropriate protease inhibitors

  • Determine protein concentration using Bradford or BCA assay

  • Prepare samples in Laemmli buffer with reducing agent

  • Heat samples at 70°C for 10 minutes (avoid boiling which can cause protein aggregation)

• Gel electrophoresis parameters:

  • Use 10-12% SDS-PAGE gels for optimal resolution

  • Load 10-50 μg of total protein per lane

  • Include molecular weight markers

• Transfer conditions:

  • Use PVDF membranes for better protein retention

  • Transfer at 100V for 1 hour in cold transfer buffer containing 20% methanol

  • Verify transfer efficiency with reversible staining

• Blocking and antibody incubation:

  • Block membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

  • Dilute At1g02060 antibody 1:1000 to 1:5000 in blocking solution

  • Incubate overnight at 4°C with gentle agitation

  • Wash thoroughly with TBST (at least 3 × 10 minutes)

  • Incubate with appropriate HRP-conjugated secondary antibody

• Detection:

  • Use enhanced chemiluminescence (ECL) detection

  • Optimize exposure times based on signal strength

  • Consider using digital imaging systems for quantitative analysis

How can researchers troubleshoot weak or absent signals when using At1g02060 antibody?

When encountering weak or absent signals with At1g02060 antibody, implement this systematic troubleshooting approach:

• Protein extraction efficiency:

  • Verify protein extraction with Coomassie staining of parallel gels

  • Test alternative extraction buffers optimized for membrane proteins

  • Include phosphatase inhibitors if phosphorylation affects antibody recognition

• Antibody quality assessment:

  • Perform dot blots with purified recombinant protein to confirm antibody activity

  • Consider affinity purification if using crude antisera

  • Test different antibody concentrations (titration series)

• Detection system optimization:

  • Extend primary antibody incubation time (up to 48 hours at 4°C)

  • Try alternative secondary antibodies

  • Consider signal amplification methods such as biotin-streptavidin systems

  • Increase exposure time during detection

• Sample preparation refinement:

  • Reduce protein denaturation temperature

  • Test non-reducing conditions if epitope involves disulfide bonds

  • Enrich target protein through subcellular fractionation

  • Concentrate samples using immunoprecipitation before analysis

• Blocking optimization:

  • Test alternative blocking agents (BSA, casein, commercial blockers)

  • Reduce blocking time or stringency if epitope binding is affected

What strategies can optimize At1g02060 antibody use in immunocytochemistry applications?

For effective immunocytochemistry with At1g02060 antibody, consider these optimization strategies:

• Fixation methods:

  Fixative	Concentration	Duration	Best For
  Paraformaldehyde	4%	30-60 min	General protein preservation
  Methanol	100%	10 min at -20°C	Cytoskeletal proteins
  Glutaraldehyde	0.1-0.5%	15-30 min	Membrane proteins
  Combined PFA/glutaraldehyde	4%/0.1%	30 min	Enhanced structural preservation

• Epitope retrieval techniques:

  • Heat-induced epitope retrieval: 10mM sodium citrate buffer (pH 6.0) at 95°C for 10-20 minutes

  • Enzymatic retrieval: Proteinase K (1-20 μg/ml) for 5-15 minutes at room temperature

  • Detergent permeabilization: 0.1-0.5% Triton X-100 for 10-30 minutes

• Signal amplification methods:

  • Tyramide signal amplification (offers 10-100× increase in sensitivity)

  • Multi-layer detection systems (biotin-streptavidin)

  • Sequential application of primary and secondary antibodies

• Background reduction:

  • Pre-adsorb antibodies with acetone powder from non-expressing tissue

  • Include 0.1-0.3M NaCl in antibody diluent to reduce ionic interactions

  • Add 0.1% Tween-20 to washing and incubation buffers

  • Use specialized blocking solutions containing both proteins and detergents

How can At1g02060 antibody contribute to protein interaction network studies?

The At1g02060 antibody can be leveraged for protein interaction network studies through these methodological approaches:

• Co-immunoprecipitation (Co-IP) protocols:

  • Crosslink proteins in vivo using membrane-permeable crosslinkers

  • Lyse cells under non-denaturing conditions

  • Perform immunoprecipitation with At1g02060 antibody

  • Analyze precipitated complexes using mass spectrometry

  • Validate interactions with reciprocal Co-IP experiments

• Proximity labeling integration:

  • Express At1g02060 fused to proximity labeling enzymes (BioID or TurboID)

  • Perform biotin labeling of proximal proteins

  • Use At1g02060 antibody to confirm correct localization of the fusion protein

  • Purify biotinylated proteins and identify interaction candidates

• Spatial co-localization studies:

  • Combine At1g02060 antibody with antibodies against candidate interacting proteins

  • Use super-resolution microscopy to analyze spatial relationships

  • Quantify co-localization using correlation coefficients

  • Perform FRET analysis if secondary antibodies are conjugated with appropriate fluorophores

What considerations are important when comparing At1g02060 localization across different developmental stages?

When investigating At1g02060 localization across developmental stages, researchers should address these critical considerations:

• Standardized sample preparation:

  • Use identical fixation protocols across all developmental stages

  • Process samples in parallel to minimize technical variation

  • Consider the differential penetration of fixatives in tissues of varying density

• Developmental stage documentation:

  • Precisely document growth conditions and developmental markers

  • Include morphological measurements to accurately stage samples

  • Consider using established staging systems specific to the organ/tissue being studied

• Quantitative assessment:

  • Implement quantitative image analysis to measure signal intensity

  • Use ratiometric measurements against stable reference proteins

  • Employ statistical methods appropriate for repeated measurements

• Controls for developmental variation:

  • Include constitutively expressed proteins as internal controls

  • Consider protein degradation rates that may vary across developmental stages

  • Account for changes in cellular organization and compartment sizes

How might At1g02060 antibody be used in combination with genetic approaches for functional validation?

Combining At1g02060 antibody with genetic approaches provides powerful strategies for functional validation:

• Mutant complementation analysis:

  • Express modified versions of At1g02060 in null mutant backgrounds

  • Use the antibody to verify protein expression and localization

  • Correlate localization patterns with complementation of mutant phenotypes

  • Identify critical domains by analyzing mislocalized variants

• Inducible expression systems:

  • Generate lines with inducible At1g02060 expression

  • Monitor protein accumulation and localization dynamics after induction

  • Correlate temporal aspects of protein accumulation with physiological responses

  • Determine minimal expression levels required for function

• CRISPR/Cas9 gene editing integration:

  • Create epitope-tagged versions of At1g02060 at the native locus

  • Compare endogenous protein localization with antibody patterns

  • Generate domain-specific mutations and monitor effects on localization

  • Use the antibody to verify protein levels in knockdown lines

What advanced imaging techniques maximize information obtained with At1g02060 antibody?

To extract maximum information from At1g02060 antibody labeling, consider these advanced imaging approaches:

• Super-resolution microscopy:

  • Stimulated Emission Depletion (STED) microscopy: Achieves resolution of 30-80 nm

  • Structured Illumination Microscopy (SIM): Provides 2× improvement over diffraction limit

  • Single Molecule Localization Microscopy (PALM/STORM): Offers precision localization to 10-20 nm

• Multi-dimensional imaging:

  • Time-lapse imaging with permeabilized cells to track dynamic processes

  • Z-stack acquisition for volumetric analysis of protein distribution

  • Spectral imaging to separate closely overlapping fluorophores

• Correlative light and electron microscopy (CLEM):

  • Perform immunofluorescence with At1g02060 antibody

  • Process the same sample for electron microscopy

  • Correlate protein localization with ultrastructural features

  • Use immunogold labeling with the same antibody for direct EM visualization

• Quantitative analysis methods:

  • Fluorescence correlation spectroscopy for protein mobility assessment

  • Fluorescence recovery after photobleaching (FRAP) for dynamic studies

  • Single particle tracking for monitoring protein movement

  • Machine learning-based segmentation and classification of localization patterns